High-dose statin use does not impair aerobic capacity or skeletal muscle function in older adults

Age

Volumn 30, Issue 4, 2008, Pages 283-291

  Traustadóttir, Tinna ^a   Stock, Anthoney A ^a   Harman, S Mitchell ^a  

^a Kronos Longevity Research Institute   (United States)

Author keywords

Aging; Myalgia; O2 uptake kinetics; Simvastatin; Strength; Vo2max

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AEROBIC CAPACITY; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MEGADOSE; ENDURANCE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MUSCLE CRAMP; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYALGIA; NORMAL HUMAN; OXYGEN CONSUMPTION; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 56749164925     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-008-9070-3     Document Type: Article

References (32)

1. American College of Sports Medicine (1991) Guidelines for exercise testing and prescription, 4th edn. Lea & Febiger, Philadelphia
2. Baechle TR, Earle RW, Wathen D (2000) Resistance training. In: Baechle TR, Earle RW (eds) Essentials of strength training and conditioning. 2nd edn. Human Kinetics, Champaign, pp 406-409
3. E Bruckert G Hayem S DeJager C Yau B Begaud 2006 Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients-The PRIMO Study Cardiovasc Drugs Ther 19 403 414
4. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al (2004) Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495-1504
5. G Caso P Kelly MA McNurian WE Lawson 2007 Effect of Coenzyme Q10 on myopathic symptoms in patients treated with statins Am J Cardiol 99 1409 1412
6. K Conley S Jubrias CE Amara DJ Marcinek 2007 Mitochondrial dysfunction: Impact on exercise performance and cellular aging Exerc Sport Sci Rev 35 43 49
7. MH Davidson JG Robinson 2007 Safety of aggressive lipid management J Am Coll Cardiol 49 1753 1762
8. J England J Walsh P Stewart I Boyd A Rohan G Halmagyi 1995 Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors- simvastatin and pravastatin Aust N Z J Med 25 374 375
9. S Franc S DeJager E Bruckert M Chauvenet P Giral G Turpin 2003 A comprehensive description of muscle symptoms associated with lipid lowering drugs Cardiovasc Drugs Ther 17 459 465
10. D Gaist L Rodriguez C Huerta J Hallas S Sindrup 2001 Lipid-lowering drugs and risk of myopathy: A population-based follow-up study Epidmiology 12 565 569
11. M Johannesson B Jönsson J Kjekshus AG Olsson TR Pedersen H Wedel 1997 Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group N Engl J Med 336 332 336
12. J Kaikkonen K Nyyssönen T-P Tuomainen U Ristonmaa JT Salonen 1999 Determinants of plasma coenzyme Q10 in humans FEBS Lett 443 163 166
13. W Kohrt M Malley A Coggan R Spina T Ogawa A Ehsani 1991 Effects of gender, age, and fitness level on response of VO2 max to training in 60-71 yr olds J Appl Physiol 71 2004 2011
14. A Lass LK Kwong RS Sohal 1999 Mitochondrial coenzyme Q content and aging Biofactors 9 199 205
15. JJ Nawarskas 2005 HMG-CoA reductase inhibitors and coenzyme Q10 Cardiol Rev 13 76 79
16. S Nissen E Tuzcu P Schoenhagen BG Brown P Ganz R Vogel 2004 Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial JAMA 291 1071 1080
17. S Nissen E Tuzcu P Schoenhagen T Crowe WJ Sasiela J Tsai 2005 Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease N Engl J Med 352 29 38
18. J Oh MR Ban BA Miskie RL Pollex RA Hegele 2007 Genetic determinants of static intolerance Lipids Health Dis 6 7 11
19. MA Omar JP Wilson TS Cox 2001 Rhabdomyolysis and HMG-CoA reductase inhibitors Ann Pharmacother 35 1096 1107
20. H Paiva KM Thelen R Van Coster J Smet B De Paepe KM Mattila 2005 High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial Clin Pharmacol Ther 78 60 68
21. RC Pasternak SC Smith Jr CN Bairey-Merz SM Grundy JI Cleeman C Lenfant 2002 ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins Stroke 33 2337 2341
22. TR Pedersen 2001 Pro and con: low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management Am J Cardiol 87 8 12
23. KF Petersen D Befroy S Dufour J Dziura C Ariyan DL Rothman 2007 Mitochondrial dysfunction in the elderly: Possible role in insulin resistance Science 300 1140 1142
24. PS Phillips RH Haas S Bannykh S Hathaway NL Gray BJ Kimura 2002 Statin-associated myopathy with normal creatine kinase levels Ann Intern Med 137 581 585
25. PS Phillips RH Haas S Bannykh S Hathaway NL Gray BJ Kimura 2002 Statin-associated myopathy with normal creatine kinase levels Ann Intern Med 137 581 585
26. PS Phillips RH Haas S Bannykh S Hathaway NL Gray BJ Kimura 2002 Statin-associated myopathy with normal creatine kinase levels Ann Intern Med 137 581 585
27. PS Phillips CT Phillips MJ Sullivan RK Naviaux RH Haas 2004 Statin myotoxicity is associated with changes in the cardiopulmonary function Atherosclerosis 177 183 188
28. LL Ploutz-Snyder EL Giamis 2001 Orientation and familiarization to 1RM strength testing in old and young women J Strength Cond Res 15 519 523
29. BA Schick R Laaksonen JJ Frohlich H Paiva T Lehtimaki KH Humphries 2007 Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin Clin Pharmacol Ther 81 650 653
30. H Sinzinger P Schmid J O'Grady 1999 Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment Atherosclerosis 143 459 460
31. PD Thompson JM Zmuda LJ Domalik RJ Zimet J Staggers JR Guyton 1997 Lovastatin increases exercise-induced skeletal muscle injury Metabolism 46 1206 1210
32. M Turunen J Olsson G Dallner 2004 Metabolism and function of coenzyme Q Biochim Biophys Acta 1660 171 199